Q03060 (CREM_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 137.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: cAMP-responsive element modulator Alternative name(s): Inducible cAMP early repressor Short name=ICER | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 361 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Transcriptional regulator that binds the cAMP response element (CRE), a sequence present in many viral and cellular promoters. Isoforms are either transcriptional activators or repressors. Plays a role in spermatogenesis and is involved in spermatid maturation By similarity. Ref.13 |
| Subunit structure | Binds DNA as a dimer. Interacts with FHL5 By similarity. Interacts with CDC34. Ref.13 |
| Subcellular location | |
| Tissue specificity | Expressed in testes (round spermatids) (at protein level). Isoform 14 is the major activator form in testes. Ref.12 Ref.14 Ref.15 |
| Post-translational modification | Isoform 9 is ubiquitinated by CDC34 and RAD6B in order to be degraded by the proteasome. Stimulated by phosphorylation By similarity. |
| Sequence similarities | Belongs to the bZIP family. Contains 1 bZIP (basic-leucine zipper) domain. Contains 1 KID (kinase-inducible) domain. |
| Sequence caution | The sequence AAB03751.1 differs from that shown. Reason: Erroneous termination at position 361. Translated as Tyr. The sequence AAF68266.2 differs from that shown. Reason: Erroneous gene model prediction. The sequence CAH72496.1 differs from that shown. Reason: Erroneous gene model prediction. The sequence CAH72497.1 differs from that shown. Reason: Erroneous gene model prediction. The sequence CAI12138.1 differs from that shown. Reason: Erroneous gene model prediction. The sequence CAI12139.1 differs from that shown. Reason: Erroneous gene model prediction. The sequence CAI12143.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Alternative products
| This entry describes 23 isoforms produced by alternative promoter usage and alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q03060-5) Also known as: CREM-BCEFGgammaHIbeta; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Note: Produced by alternative promoter usage. | ||||||
| Isoform 2 (identifier: Q03060-1) Also known as: Beta; CREM-BCEFGHIbeta; The sequence of this isoform differs from the canonical sequence as follows: 249-260: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 1. Activator. | ||||||
| Isoform 3 (identifier: Q03060-6) Also known as: CREM-BCEFGIalpha; Tau; The sequence of this isoform differs from the canonical sequence as follows: 249-260: Missing. 317-361: KECRRRKKEY...KDICSPKTDY → RECRRKKKEY...LKDLYCHKVE | ||||||
| Note: Produced by alternative splicing of isoform 1. Activator. | ||||||
| Isoform 4 (identifier: Q03060-2) Also known as: Alpha; CREM-BEFHIb; CREM-gamma; The sequence of this isoform differs from the canonical sequence as follows: 58-106: Missing. 186-248: Missing. 249-260: Missing. 261-261: A → T | ||||||
| Note: Produced by alternative splicing of isoform 1. | ||||||
| Isoform 5 (identifier: Q03060-7) Also known as: CREM-theta2tau-gamma; CREM-theta2EFGHIb; The sequence of this isoform differs from the canonical sequence as follows: 1-104: Missing. 105-105: Q → M 249-260: Missing. | ||||||
| Note: Produced by alternative promoter usage. Activator. | ||||||
| Isoform 6 (identifier: Q03060-8) Also known as: CREM2alpha-a; IcergammaHIalpha; ICER1; ICERI; The sequence of this isoform differs from the canonical sequence as follows: 1-240: Missing. 241-248: PGSQVVVQ → MAVTGDDT 317-361: KECRRRKKEY...KDICSPKTDY → RECRRKKKEY...LKDLYCHKVE | ||||||
| Note: Produced by alternative promoter usage. Repressor. | ||||||
| Isoform 7 (identifier: Q03060-9) Also known as: CREM2alpha-b; IcerHIalpha; ICERIgamma; The sequence of this isoform differs from the canonical sequence as follows: 1-240: Missing. 241-248: PGSQVVVQ → MAVTGDDT 249-260: Missing. 317-361: KECRRRKKEY...KDICSPKTDY → RECRRKKKEY...LKDLYCHKVE | ||||||
| Note: Produced by alternative splicing of isoform 6. Repressor. | ||||||
| Isoform 8 (identifier: Q03060-10) Also known as: CREM 2beta-a; IcergammaHIbeta; ICERII; The sequence of this isoform differs from the canonical sequence as follows: 1-240: Missing. 241-248: PGSQVVVQ → MAVTGDDT | ||||||
| Note: Produced by alternative splicing of isoform 6. Repressor. | ||||||
| Isoform 9 (identifier: Q03060-11) Also known as: CREM 2beta-b; IcerHIbeta; ICERIIgamma; The sequence of this isoform differs from the canonical sequence as follows: 1-240: Missing. 241-248: PGSQVVVQ → MAVTGDDT 249-260: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 6. Repressor. | ||||||
| Isoform 10 (identifier: Q03060-12) Also known as: CREMtheta1tau2beta; CREM-theta1EFGHIbeta; The sequence of this isoform differs from the canonical sequence as follows: 1-104: Missing. 105-105: Q → MWWHQHNLCFRRPIEEDYSSGDVEEK 249-260: Missing. | ||||||
| Note: Produced by alternative promoter usage. Activator. | ||||||
| Isoform 11 (identifier: Q03060-13) Also known as: CREM-theta1beta; CREM-theta1EFHIbeta; The sequence of this isoform differs from the canonical sequence as follows: 1-104: Missing. 105-105: Q → MWWHQHNLCFRRPIEEDYSSGDVEEK 186-248: Missing. 261-261: A → T | ||||||
| Note: Produced by alternative splicing of isoform 10. Repressor. | ||||||
| Isoform 12 (identifier: Q03060-14) Also known as: CREM-theta2beta; CREM-theta2EFHIb; CREM-theta2-gamma; The sequence of this isoform differs from the canonical sequence as follows: 1-104: Missing. 105-105: Q → M 186-248: Missing. 261-261: A → T | ||||||
| Note: Produced by alternative splicing of isoform 5. Repressor. | ||||||
| Isoform 13 (identifier: Q03060-15) Also known as: CREM-BEFGgammaHIbeta; The sequence of this isoform differs from the canonical sequence as follows: 58-106: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 1. Activator. | ||||||
| Isoform 14 (identifier: Q03060-16) Also known as: CREM-tau2-gamma; CREM-BEFGHIbeta; The sequence of this isoform differs from the canonical sequence as follows: 58-106: Missing. 249-260: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 1. Activator. | ||||||
| Isoform 15 (identifier: Q03060-17) Also known as: CREM-BGHIbeta; The sequence of this isoform differs from the canonical sequence as follows: 58-106: Missing. 107-185: Missing. 249-260: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 1. Repressor. | ||||||
| Isoform 16 (identifier: Q03060-19) Also known as: CREM-deltaC-G; CREM-BgammaHIbeta; The sequence of this isoform differs from the canonical sequence as follows: 58-106: Missing. 107-185: Missing. 186-248: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 1. Repressor. | ||||||
| Isoform 17 (identifier: Q03060-20) Also known as: CREM-BHIbeta; The sequence of this isoform differs from the canonical sequence as follows: 186-248: Missing. 249-260: Missing. | ||||||
| Note: Produced by alternative splicing of isoform 1. Repressor. | ||||||
| Isoform 18 (identifier: Q03060-21) Also known as: CREM-BHIalpha; The sequence of this isoform differs from the canonical sequence as follows: 186-248: Missing. 249-260: Missing. 317-361: KECRRRKKEY...KDICSPKTDY → RECRRKKKEY...LKDLYCHKVE | ||||||
| Note: Produced by alternative splicing of isoform 1. Repressor. | ||||||
| Isoform 19 (identifier: Q03060-22) Also known as: CREM-theta1tau2gamma; CREM-theta1EFGgammaHIbeta; The sequence of this isoform differs from the canonical sequence as follows: 1-104: Missing. 105-105: Q → MWWHQHNLCFRRPIEEDYSSGDVEEK | ||||||
| Note: Produced by alternative splicing of isoform 10. Activator. | ||||||
| Isoform 20 (identifier: Q03060-23) The sequence of this isoform differs from the canonical sequence as follows: 1-104: Missing. 105-258: Missing. 317-361: KECRRRKKEY...KDICSPKTDY → RECRRKKKEY...LKDLYCHKVE | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 21 (identifier: Q03060-24) The sequence of this isoform differs from the canonical sequence as follows: 1-12: MSKCARKKYIKT → MNRTQELSGQLS 13-260: Missing. 317-361: KECRRRKKEY...KDICSPKTDY → RECRRKKKEY...LKDLYCHKVE | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 22 (identifier: Q03060-25) The sequence of this isoform differs from the canonical sequence as follows: 1-16: Missing. 58-106: Missing. 186-202: IAIAQGGTIQISNPGSD → SMYAAIRYDTVLALSLL 203-361: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 23 (identifier: Q03060-26) The sequence of this isoform differs from the canonical sequence as follows: 58-106: Missing. 186-248: Missing. 249-249: D → N 317-361: KECRRRKKEY...KDICSPKTDY → RECRRKKKEY...LKDLYCHKVE |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 361 | 361 | cAMP-responsive element modulator | PRO_0000076607 | |||||
Regions | |||||||||
| Domain | 104 – 163 | 60 | KID | ||||||
| Domain | 302 – 361 | 60 | bZIP | ||||||
| Region | 303 – 328 | 26 | Basic motif By similarity | ||||||
| Region | 330 – 351 | 22 | Leucine-zipper By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 287 | 1 | Phosphoserine Ref.16 Ref.17 | ||||||
| Modified residue | 290 | 1 | Phosphoserine Ref.16 | ||||||
| Modified residue | 293 | 1 | Phosphoserine Ref.16 Ref.17 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 240 | 240 | Missing in isoform 6, isoform 7, isoform 8 and isoform 9. | VSP_026075 | |||||
| Alternative sequence | 1 – 104 | 104 | Missing in isoform 5, isoform 10, isoform 11, isoform 12, isoform 19 and isoform 20. | VSP_025035 | |||||
| Alternative sequence | 1 – 16 | 16 | Missing in isoform 22. | VSP_043782 | |||||
| Alternative sequence | 1 – 12 | 12 | MSKCA…KYIKT → MNRTQELSGQLS in isoform 21. | VSP_043713 | |||||
| Alternative sequence | 13 – 260 | 248 | Missing in isoform 21. | VSP_043714 | |||||
| Alternative sequence | 58 – 106 | 49 | Missing in isoform 4, isoform 13, isoform 14, isoform 15, isoform 16, isoform 22 and isoform 23. | VSP_000599 | |||||
| Alternative sequence | 105 – 258 | 154 | Missing in isoform 20. | VSP_043580 | |||||
| Alternative sequence | 105 | 1 | Q → MWWHQHNLCFRRPIEEDYSS GDVEEK in isoform 10, isoform 11 and isoform 19. | VSP_026076 | |||||
| Alternative sequence | 105 | 1 | Q → M in isoform 5 and isoform 12. | VSP_025036 | |||||
| Alternative sequence | 107 – 185 | 79 | Missing in isoform 15 and isoform 16. | VSP_026077 | |||||
| Alternative sequence | 186 – 248 | 63 | Missing in isoform 4, isoform 11, isoform 12, isoform 16, isoform 17, isoform 18 and isoform 23. | VSP_000600 | |||||
| Alternative sequence | 186 – 202 | 17 | IAIAQ…NPGSD → SMYAAIRYDTVLALSLL in isoform 22. | VSP_043783 | |||||
| Alternative sequence | 203 – 361 | 159 | Missing in isoform 22. | VSP_043784 | |||||
| Alternative sequence | 241 – 248 | 8 | PGSQVVVQ → MAVTGDDT in isoform 6, isoform 7, isoform 8 and isoform 9. | VSP_026078 | |||||
| Alternative sequence | 249 – 260 | 12 | Missing in isoform 2, isoform 3, isoform 4, isoform 5, isoform 7, isoform 9, isoform 10, isoform 14, isoform 15, isoform 17 and isoform 18. | VSP_025037 | |||||
| Alternative sequence | 249 | 1 | D → N in isoform 23. | VSP_045234 | |||||
| Alternative sequence | 261 | 1 | A → T in isoform 4, isoform 11 and isoform 12. | VSP_000601 | |||||
| Alternative sequence | 317 – 361 | 45 | KECRR…PKTDY → RECRRKKKEYVKCLENRVAV LENQNKTLIEELKALKDLYC HKVE in isoform 3, isoform 6, isoform 7, isoform 18, isoform 20, isoform 21 and isoform 23. | VSP_025038 | |||||
| Natural variant | 270 | 1 | Q → R. Ref.2 Corresponds to variant rs1804604 [ dbSNP | Ensembl ]. | VAR_055561 | |||||
Experimental info | |||||||||
| Sequence conflict | 49 | 1 | N → I in AAC60616. Ref.11 | ||||||
| Sequence conflict | 49 | 1 | N → I in AAC60617. Ref.11 | ||||||
| Sequence conflict | 55 | 1 | A → R in CAA78858. Ref.10 | ||||||
| Sequence conflict | 57 – 61 | 5 | VSVAG → CSELR in AAC60616. Ref.11 | ||||||
| Sequence conflict | 57 – 61 | 5 | VSVAG → CSELR in AAC60617. Ref.11 | ||||||
| Sequence conflict | 292 | 1 | H → R in BAA03562. Ref.1 | ||||||
| Sequence conflict | 292 | 1 | H → R in BAA03564. Ref.3 | ||||||
| Sequence conflict | 292 | 1 | H → R in BAA03565. Ref.3 | ||||||
| Sequence conflict | 292 | 1 | H → R in BAA03566. Ref.3 | ||||||
| Sequence conflict | 292 | 1 | H → R in BAA03567. Ref.3 | ||||||
| Isoform 6: | |||||||||
| Sequence conflict | 7 | 1 | D → E in AAC19383. Ref.3 | ||||||
| Sequence conflict | 112 | 1 | K → R in AAC19383. Ref.3 | ||||||
| Isoform 8: | |||||||||
| Sequence conflict | 7 | 1 | D → E in AAB03751. Ref.2 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Novel isoforms of human cyclic AMP-responsive element modulator (hCREM) mRNA." Fujimoto T., Fujisawa J., Yoshida M. J. Biochem. 115:298-303(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 6; 7; 8; 9 AND 23). |
| [2] | "cAMP inducibility of transcriptional repressor ICER in developing and mature human T lymphocytes." Bodor J., Spetz A.L., Strominger J.L., Habener J.F. Proc. Natl. Acad. Sci. U.S.A. 93:3536-3541(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 8), ALTERNATIVE SPLICING (ISOFORMS 6; 7 AND 9), VARIANT ARG-270. |
| [3] | "Human ICER1, a predicted alternative splice form of CREM, is evident in JEG-3 cells." Brodie C.R., Boland L.M., Orr H.T. Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6). |
| [4] | "The function of an isoform of hCREM gene in testis development." Lu L., Huang X.Y., Xu M., Xu Z.Y., Li J.M., Zhou Z.M., Sha J.H. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5). Tissue: Testis. |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5; 7; 20 AND 21). Tissue: Adrenal gland, Heart, Placenta and Testis. |
| [6] | "The DNA sequence and comparative analysis of human chromosome 10." Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., Taylor A., Battles J. Rogers J.Nature 429:375-381(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5 AND 22). Tissue: Brain, Testis and Uterus. |
| [8] | "Searching for mutations in the human cAMP responsive element modulator (CREM) gene." Vouk K., Lalli E., Scherer S.W., Sassone-Corsi P., Debeljak N., Komel R., Rozman D. Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-248. |
| [9] | "Novel leader exons of the cyclic adenosine 3',5'-monophosphate response element modulator (CREM) gene, transcribed from promoters P3 and P4, are highly testis-specific in primates." Gellersen B., Kempf R., Sandhowe R., Weinbauer G.F., Behr R. Mol. Hum. Reprod. 8:965-976(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-26 (ISOFORM 10), ALTERNATIVE SPLICING (ISOFORMS 5; 10; 11 AND 12). |
| [10] | "Human CREM gene: evolutionary conservation, chromosomal localization, and inducibility of the transcript." Masquilier D., Foulkes N.S., Mattei M.-G., Sassone-Corsi P. Cell Growth Differ. 4:931-937(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 17-361 (ISOFORMS 2 AND 3). |
| [11] | "Cyclic AMP response element binding protein CREB and modulator protein CREM are products of distinct genes." Meyer T.E., Habener J.F. Nucleic Acids Res. 20:6106-6106(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 17-360 (ISOFORM 4). Tissue: Placenta. |
| [12] | "Combinations of genetic changes in the human cAMP-responsive element modulator gene: a clue towards understanding some forms of male infertility?" Vouk K., Hudler P., Strmsnik L., Fink M., Majdic G., Zorn B., Lalli E., Sassone-Corsi P., Debeljak N., Komel R., Rozman D. Mol. Hum. Reprod. 11:567-574(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 262-361, TISSUE SPECIFICITY. |
| [13] | "Human Cdc34 and Rad6B ubiquitin-conjugating enzymes target repressors of cyclic AMP-induced transcription for proteolysis." Pati D., Meistrich M.L., Plon S.E. Mol. Cell. Biol. 19:5001-5013(1999) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH CDC34, UBIQUITINATION. |
| [14] | "CREM activator and repressor isoforms in human testis: sequence variations and inaccurate splicing during impaired spermatogenesis." Behr R., Weinbauer G.F. Mol. Hum. Reprod. 6:967-972(2000) [PubMed] [Europe PMC] [Abstract] Cited for: ALTERNATIVE SPLICING (ISOFORMS 2; 4; 13; 15; 17 AND 18), TISSUE SPECIFICITY. |
| [15] | "Different CREM-isoform gene expression between equine and human normal and impaired spermatogenesis." Bloecher S., Behr R., Weinbauer G.F., Bergmann M., Steger K. Theriogenology 60:1357-1369(2003) [PubMed] [Europe PMC] [Abstract] Cited for: ALTERNATIVE SPLICING (ISOFORMS 5; 12; 14; 16 AND 19), TISSUE SPECIFICITY. |
| [16] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287; SER-290 AND SER-293, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [17] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287 AND SER-293, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | D14825 mRNA. Translation: BAA03562.1. D14826 mRNA. Translation: BAA03564.1. D14826 mRNA. Translation: BAA03565.1. D14826 mRNA. Translation: BAA03566.1. D14826 mRNA. Translation: BAA03567.1. U44836 mRNA. Translation: AAB03751.1. Sequence problems. AF069065 mRNA. Translation: AAC19383.1. AY292864 mRNA. Translation: AAP44115.1. AK289379 mRNA. Translation: BAF82068.1. AK290612 mRNA. Translation: BAF83301.1. AK291566 mRNA. Translation: BAF84255.1. AK301906 mRNA. Translation: BAG63333.1. AL117336, AL157783 Genomic DNA. Translation: CAH72495.1. AL117336, AL157783 Genomic DNA. Translation: CAH72496.1. Sequence problems. AL117336, AL157783 Genomic DNA. Translation: CAH72497.1. Sequence problems. AL117336, AL157783 Genomic DNA. Translation: CAH72499.1. AL117336, AL157783 Genomic DNA. Translation: CAH72500.1. AL157783, AL117336 Genomic DNA. Translation: CAI12137.1. AL157783, AL117336 Genomic DNA. Translation: CAI12138.1. Sequence problems. AL157783, AL117336 Genomic DNA. Translation: CAI12139.1. Sequence problems. AL157783 Genomic DNA. Translation: CAI12141.1. AL157783 Genomic DNA. Translation: CAI12143.1. Sequence problems. AL157783, AL117336 Genomic DNA. Translation: CAI12145.1. AL157783, AL117336 Genomic DNA. Translation: CAI12147.1. CH471072 Genomic DNA. Translation: EAW85918.1. BC017117 mRNA. Translation: AAH17117.1. BC066342 mRNA. Translation: AAH66342.1. BC090051 mRNA. Translation: AAH90051.1. AF213899 AF213898 Genomic DNA. Translation: AAF68266.2. Sequence problems.AF417234 mRNA. Translation: AAN32656.1. S68271 mRNA. Translation: AAC60616.2. S68134 mRNA. Translation: AAC60617.2. Z15159 mRNA. Translation: CAA78858.1. AF217318, AF214665 Genomic DNA. Translation: AAF66158.2. AF217318, AF214665 Genomic DNA. Translation: AAF68682.1. |
| IPI | IPI00014322. IPI00216396. IPI00337311. IPI00337364. IPI00337365. IPI00337613. IPI00375605. IPI00375650. IPI00376141. IPI00377146. IPI00641528. IPI00748922. IPI00847200. IPI00847295. IPI00847382. IPI00847411. IPI00847491. IPI00847704. IPI00847842. IPI00848007. IPI00848206. IPI00848332. |
| PIR | JC2087. JC6135. JX0307. S26685. |
| RefSeq | NP_001254491.1. NM_001267562.1. NP_001254493.1. NM_001267564.1. NP_001254499.1. NM_001267570.1. NP_001872.3. NM_001881.3. NP_853549.1. NM_181571.2. NP_874386.1. NM_182717.1. NP_874387.1. NM_182718.1. NP_874388.1. NM_182719.1. NP_874389.1. NM_182720.1. NP_874390.1. NM_182721.1. NP_874392.1. NM_182723.1. NP_874393.1. NM_182724.1. NP_877570.1. NM_182769.2. NP_877571.1. NM_182770.2. NP_877572.1. NM_182771.1. NP_877573.1. NM_182772.1. NP_898829.1. NM_183011.1. NP_898830.1. NM_183012.1. NP_898831.1. NM_183013.2. |
| UniGene | Hs.200250. Hs.686182. |
3D structure databases | |
| ProteinModelPortal | Q03060. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q03060. 6 interactions. |
PTM databases | |
| PhosphoSite | Q03060. |
Polymorphism databases | |
| DMDM | 259016392. |
Proteomic databases | |
| PaxDb | Q03060. |
| PRIDE | Q03060. |
Protocols and materials databases | |
| DNASU | 1390. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000333809; ENSP00000333055; ENSG00000095794. ENST00000342105; ENSP00000341875; ENSG00000095794. ENST00000345491; ENSP00000265372; ENSG00000095794. ENST00000354759; ENSP00000346804; ENSG00000095794. ENST00000356917; ENSP00000349387; ENSG00000095794. ENST00000361599; ENSP00000354593; ENSG00000095794. ENST00000374722; ENSP00000363854; ENSG00000095794. ENST00000374726; ENSP00000363858; ENSG00000095794. ENST00000395887; ENSP00000379225; ENSG00000095794. ENST00000395895; ENSP00000379232; ENSG00000095794. ENST00000473940; ENSP00000420681; ENSG00000095794. ENST00000474931; ENSP00000417562; ENSG00000095794. ENST00000479070; ENSP00000420511; ENSG00000095794. ENST00000487763; ENSP00000417807; ENSG00000095794. ENST00000488328; ENSP00000417460; ENSG00000095794. ENST00000488741; ENSP00000419075; ENSG00000095794. ENST00000489321; ENSP00000419924; ENSG00000095794. |
| GeneID | 1390. |
| KEGG | hsa:1390. |
| UCSC | uc001iyb.3. human. uc001iyf.3. human. uc001iyh.3. human. uc001iyl.3. human. uc001iyn.3. human. |
Organism-specific databases | |
| CTD | 1390. |
| GeneCards | GC10P035415. |
| HGNC | HGNC:2352. CREM. |
| HPA | CAB018352. HPA001818. |
| MIM | 123812. gene. |
| neXtProt | NX_Q03060. |
| PharmGKB | PA26871. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG300199. |
| HOGENOM | HOG000007365. |
| HOVERGEN | HBG011077. |
| InParanoid | Q03060. |
| KO | K09052. |
| OMA | ESESAHM. |
Gene expression databases | |
| ArrayExpress | Q03060. |
| Bgee | Q03060. |
| Genevestigator | Q03060. |
| GermOnline | ENSG00000095794. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR004827. bZIP. IPR003102. Coactivator_CBP_pKID. IPR001630. Leuzip_CREB. [Graphical view] |
| Pfam | PF00170. bZIP_1. 1 hit. PF02173. pKID. 1 hit. [Graphical view] |
| PRINTS | PR00041. LEUZIPPRCREB. |
| SMART | SM00338. BRLZ. 1 hit. [Graphical view] |
| PROSITE | PS50217. BZIP. 1 hit. PS00036. BZIP_BASIC. 1 hit. PS50953. KID. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | CREM. human. |
| GenomeRNAi | 1390. |
| NextBio | 5649. |
| SOURCE | Search... |
Entry information
| Entry name | CREM_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q03060 Secondary accession number(s): A8K014 Q9NZB9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 10 Human chromosome 10: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
